Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy

N Engl J Med. 2020 Jan 16;382(3):294-296. doi: 10.1056/NEJMc1912274.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / adverse effects*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / secondary
  • Colitis / chemically induced
  • Colitis / immunology
  • Colitis / therapy*
  • Colon / pathology
  • Colonoscopy
  • Glucocorticoids / therapeutic use
  • Humans
  • Ipilimumab / adverse effects*
  • Killer Cells, Natural*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Nivolumab / adverse effects*
  • Photopheresis*
  • Programmed Cell Death 1 Receptor

Substances

  • Antineoplastic Agents, Immunological
  • Glucocorticoids
  • Ipilimumab
  • Programmed Cell Death 1 Receptor
  • Nivolumab